Moto Yaga

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Renewed Response to Pembrolizumab After Salvage Radiotherapy for Oligoprogression in Advanced NSCLC: A Case Report.

Renewed Response to Pembrolizumab After Salvage Radiotherapy for Oligoprogression in Advanced NSCLC: A Case Report.

Journal: Respirology case reports
Published: April 10, 2026

Endobronchial Watanabe Spigot for Acute Empyema With Bronchopleural Fistula: A Case Series.

Endobronchial Watanabe Spigot for Acute Empyema With Bronchopleural Fistula: A Case Series.

Journal: Respirology case reports
Published: October 07, 2025

A case of EGFR-positive lung adenocarcinoma that once transformed into small cell carcinoma but worsened into adenocarcinoma again.

A case of EGFR-positive lung adenocarcinoma that once transformed into small cell carcinoma but worsened into adenocarcinoma again.

Journal: Respiratory medicine case reports
Published: December 13, 2024

Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensate.

Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensate.

Journal: The journal of allergy and clinical immunology. Global
Published: September 10, 2024

Usefulness of net retrieval devices for central airway obstruction caused by blood clots during extracorporeal membrane oxygenation: Case series.

Usefulness of net retrieval devices for central airway obstruction caused by blood clots during extracorporeal membrane oxygenation: Case series.

Journal: Medicine
Published: July 26, 2024

Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma.

Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma.

Journal: Cancer immunology, immunotherapy : CII
Published: June 22, 2024

CAR-NK cells derived from cord blood originate mainly from CD56-CD7+CD34-HLA-DR-Lin- NK progenitor cells.

CAR-NK cells derived from cord blood originate mainly from CD56-CD7+CD34-HLA-DR-Lin- NK progenitor cells.

Journal: Molecular therapy. Methods & clinical development
Published: April 16, 2024

Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model.

Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model.

Journal: Cancer immunology, immunotherapy : CII
Published: April 01, 2024

CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy.

CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy.

Journal: Scientific reports
Published: February 08, 2024

SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis.

SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis.

Journal: JCI insight
Published: November 28, 2023

CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant.

CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant.

Journal: Nature cancer
Published: September 23, 2023

Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.

Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.

Journal: Science advances
Published: May 19, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026